It's All About/Research Funding/Torrington/Type None Diabetes
View our Web Page http://weneedyou.jdrftype1.com
Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. JDRF is the only organization with a strategic research plan to end T1D. Our strategies include: Artificial Pancreas Systems Artificial pancreas systems will eliminate blood glucose testing and carb counting by totally automating insulin dosing, initially preventing dangerous low blood sugars and eventually ensuring ideal glucose control. Complications JDRF’s complications research is leading to therapies to treat and even reverse some of the debilitating, costly, and life-threatening complications caused by T1D. Encapsulation JDRF’s encapsulation research will restore insulin independence for 18 months to two years
by implanting newly created beta cells into a protective capsule, which eliminates the need for toxic immune suppression therapies. Juvenile Diabetes fund for the arts Kentucky and Southern Indiana Chapter Alfred Gerriets donor Full list of Video Credit see here http://broadcaster.beazil.net/public/credits/youtube/videos/43881 Type 1 diabetes (Juvenile Diabetes) is usually diagnosed in children and young adults, and was previously known as juvenile diabetes. Only 5% of people with diabetes have this form of the disease.
In type 1 diabetes, the body does not produce insulin. The body breaks down the sugars and starches you eat into a simple sugar called glucose, which it uses for energy. Insulin is a hormone that the body needs to get glucose from the bloodstream into the cells of the body. With the help of insulin therapy and other treatments, even young children can learn to manage their condition and live long, healthy lives.
18.2 million people in the United States (6.3 percent of the population) have been diagnosed with diabetes. 5 to 10 percent of all people with diabetes have Type 1 Diabetes (T1D). Main Street Marketplace (MSMP) was created in 2009 by founders Steve Criss, Rose Ponte, Jessica Hodorski and the 2009 ACT Commissioners. The original idea for MSMP was to create an event to bring families together downtown to support the local merchants. Since 2009, MSMP brings in about 3,000 visitors a night, has 40-45 exhibitors, 15-20 food vendors, non-profit exhibitors, and a variety of different types of performers every night. It is an 8-week event that runs consecutively during the summer on Thursday nights from 5 to 9 o’clock. Main Street is shut down and the marketplace extends from Water Street to Alvord Street. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
Inform yourself at http://jdrf.org/blog/
Give our Google Plus account a LIKE https://plus.google.com/110620633690555176280/
Leave us a comment on https://www.youtube.com/user/jdrfonline
Go to our Facebook account https://www.facebook.com/myJDRF
Get familiar with our Twitter https://twitter.com/JDRFTypeOne
Join us at our Linkedin account https://www.linkedin.com/company/jdrf
Subscribe at our Instagram account https://www.instagram.com/jdrfadvocacy/
See more at https://www.pinterest.com/jdrfadvocacy/
In general, it’s all about:
LADA,new treatment,Random Plasma Glucose Test,insulin strength,GMP,Cure,Regular Acting Insulin,preventive therapies,multiple-dose insulin,Type 1 Diabetes,TypeOnesie,triglyceride,GLP-1 agonists,Stoke,protease inhibitors,interstitial glucose,grassroots fundraising,Research Grants,NDEP,UKPDS Study,Sodium–glucose cotransporter 2 inhibitors,funding research,ACCORD Trial,using insulin,Promise Gala,Pathaway to Prevention,patient-driven care,sorbitol,JDRF Mentor Program,T1D management,Insulin Pump Therapy,neonatal diabetes,MultiPepT1De,diabetes prevention program,funding,become an advocate,IFG,Smart Insulin,Pre- Diabetes,CDE,b-cell.